Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial.
👥 作者
Mulvagh SL
Inzucchi SE
Marx N
Poulter NR
Deanfield JE
Pop-Busui R
Emerson SS
Mann JFE
Engelmann MDM
Hovingh GK
Mandavya K
Davicevic-Elez Z
Jeppesen OK
Lorenzatti A
Oguz A
Mankovsky B
Deerochanawong C
Gorgojo-Martinez JJ
Ji L
Bain SC
McGuire DK
Buse JB
SOUL Study Group